Article Listing - Generics

Fujifilm and Dr Reddy's abandon plans for generics JV in Japan

4 June 2013

Japan's Fujifilm Corp and Indian drugmaker Dr Reddy's Laboratories (NYSE: RDY) have decided to terminate the Memorandum of Understanding to enter into an exclusive partnership in the generic drugs business for the Japanese market and to establish a joint venture in Japan.

AstraZeneca settles with Hanmi and Amneal over Nexium; Prepares for olaparib regulatory filing

3 June 2013

Anglo-Swedish drug major AstraZeneca (LSE: AZN) today (May 3) said it has entered into an agreement with South Korean firm Hanmi Pharmaceutical and its US marketing partner, privately-held generics drugmaker Amneal Pharmaceuticals, to resolve certain issues and appeal others in US Nexium (esomeprazole) patent litigation regarding Hanmi's Esomeprazole Strontium 505(b)2 NDA product. The agreement eliminates the need for a trial at the US District Court for the District of New Jersey, thus avoiding considerable trial costs.

Shire settles Intuniv patent infringement law suit against Teva concerning

3 June 2013

Ireland-headquartered drugmaker Shire (LSE: SHP) has settled its litigation against the US subsidiary of Israel's Teva Pharmaceutical Industries (NYSE: TEVA) in connection with Teva's Abbreviated New Drug Application for a generic version of Shire's Intuniv (guanfacine) extended release Tablets for the treatment of attention-deficit hyperactivity disorder (ADHD).

CPhI Russia highlights growth in domestic manufacturing and international partnering

31 May 2013

Presentations at the CPhI Russia event which took place in April reflected growth in the Russian pharma market and brought together senior Russian pharma professionals and international pharmaceutical suppliers and buyers.

Zydus Cadila's net profit up by 54% in fourth qtr

30 May 2013

Indian drugmaker Zydus Cadila posted results for the fourth quarter ended March 31, 2013, showing that net profit for the period leapt 54% to 2.63 billion rupees ($47.3 million) and claiming these were "excellent" results.

UNITAID market power results in price cuts of up to 80% for HIV/AIDS, TB and malaria products

30 May 2013

UNITAID's approach to transform health product markets has delivered price reductions of up to 80% for HIV/AIDS, tuberculosis and malaria medicines and diagnostics for the world's poor, according to the just released Results Beyond Investment, its 2012 Annual Report.

Ireland passes legislation for reference pricing of drugs and increased generics use

29 May 2013

Irish Parliamentarians last week passed the country's Health (Pricing and Supply of Medical Goods) Bill 2012 through both Houses of the Oireachtas, moves that were welcomed by Health Minister James Reilly and Alex White, Minister of State with responsibility for Primary Care in the Department of Health.

Russian government may change mechanism of price regulation for vital drugs

29 May 2013

Sales of essential and vital drugs in Russia rose by 16% to 37.85 billion roubles ($1.21 billion) in the first quarter of the current year, according to data provided by IMS Health Russia during the recent Russian pharmaceutical forum organized by the Adam Smith Institute.

Government health care reforms foster development China's Pharma market, says F&S

28 May 2013

Rising incomes, improving health care infrastructure and enhanced insurance systems have propelled the Chinese pharmaceutical market to become the third-largest in the world. The entry of multinational companies has granted local manufacturers access to advanced technologies and further aided market development in the country.

Switzerland's Lonza involvement in South Africa pharma project in doubt

28 May 2013

The South Africa government is expected to publish a request for information from potential international, domestic technology and investment partners on Friday for its pharmaceutical company after Swiss drugmaker Lonza (SIX: LONN) pulled out of a collaboration, reports Ventures Africa. The state-owned pharmaceutical company will manufacture key ingredients for AIDS drugs.

Showing 21-30 of 1496 articles